Krystal Biotech KRYS
$308.89 −$6.93 (-2.19%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $308.85 -0.01%
Open$313.38
Prev close$315.82
Day range$308.22 – $321.27
Volume286.7K
Market cap$9.15B
P/E (TTM)42.0
Dividend yield–
Earnings
Average move on report day±10.7%last 13 reports
Closed higher5 of 1338% of the time
Best reaction+41.0%
Worst reaction-15.0%
Stock move on the day after each report
| Quarter | Report date | Timing | Implied move | Actual move | Versus implied |
|---|---|---|---|---|---|
| 2026/Q3 | 2 Nov 2026 | Pre Market | ±8.9% | -10.95% | Bigger than priced |
| 2026/Q2 | 3 Aug 2026 | Pre Market | ±10.7% | -8.37% | Within range |
| 2026/Q1 | 4 May 2026 | Pre Market | ±8.3% | +7.86% | Within range |
| 2025/Q4 | 17 Feb 2026 | Pre Market | ±8.1% | +4.12% | Within range |
| 2025/Q3 | 3 Nov 2025 | Pre Market | ±11.4% | +0.17% | Within range |
| 2025/Q2 | 4 Aug 2025 | Pre Market | ±11.5% | -14.04% | Bigger than priced |
| 2025/Q1 | 6 May 2025 | Pre Market | ±11.0% | -14.06% | Bigger than priced |
| 2024/Q4 | 19 Feb 2025 | Pre Market | ±13.3% | +12.43% | Within range |
| 2024/Q3 | 4 Nov 2024 | Pre Market | ±13.9% | -3.14% | Within range |
| 2024/Q2 | 5 Aug 2024 | Pre Market | ±15.0% | -5.85% | Within range |
| 2024/Q1 | 6 May 2024 | Pre Market | ±13.0% | -2.58% | Within range |
| 2023/Q4 | 26 Feb 2024 | Pre Market | ±17.0% | +41.02% | Bigger than priced |
| 2023/Q3 | 6 Nov 2023 | Pre Market | ±13.9% | -15.05% | Bigger than priced |
"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$127.34M+30.2% YoY
Operating profit$71.15M+72.0% YoY
Net profit$63.07M-20.5% YoY
Diluted EPS$2.05-22.9% YoY
Free cash flow$90.25M+137.8% YoY
Operating cash flow$91.25M
Revenue, last 8 quarters
Net profit, last 8 quarters
Profitability & balance sheet
Gross margin94.3%
Operating margin48.4%
Net margin47.9%
Return on equity17.5%
Return on assets15.9%
Return on invested capital15.3%
Current ratio7.89
Liabilities / assets9.5%
Cash & investments$911.85M
Total debt$6.77M
Net cash (debt)$905.08M
Free cash flow / sales66.0%
No comments yet — be the first to weigh in on KRYS.
Sign in to join the discussion.